VIENNA, Austria—More data are confirming that if femoral access isn’t possible for transcatheter aortic valve replacement, then operators should at the very least stay out of the thorax when ...
WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...
Munich, Germany – 19 February 2026: With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve ...
The randomized ACCESS-TAVI study led by PD Dr. Tobias Rheude and DZHK-Prof. Michael Joner from the German Heart Center Munich and the German Center for Cardiovascular Research shows that a combined ...
With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at ...
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were ...
In that high-risk group, in-hospital mortality was "just as good, if not better" with TAVI as with conventional aortic-valve surgery, said Dr Christian W Hamm (Kerckhoff Heart and Thorax Centre, Bad ...
A study published today in the New England Journal of Medicine (NEJM) found that among patients with aortic stenosis undergoing transfemoral transcatheter aortic-valve replacement (TAVR), the use of a ...
Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late ...
BURLINGAME, Calif., Oct. 23, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced initiation of enrolment in its North American Early Feasibility Study using its ...
LONDON — Continuing oral anticoagulant drugs rather than briefly stopping them during transcatheter aortic valve implantation (TAVI) failed to provide any benefits and, in fact, increased the risk for ...